REMICADE (INFLIXIMAB) — NDC 57894-030 by Janssen Biotech, Inc.
REMICADE (INFLIXIMAB) — NDC 57894-030 by Janssen Biotech, Inc. is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: REMICADE; Generic name: INFLIXIMAB; Product NDC: 57894-030.
| Brand name | REMICADE |
|---|---|
| Generic name | INFLIXIMAB |
| Product NDC | 57894-030 |
| Labeler | Janssen Biotech, Inc. |
| Dosage form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active ingredients | INFLIXIMAB 100 mg/10mL |
| Pharmacologic class | Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA] |
| Marketing category | BLA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →